Date published: 2025-10-10

021-6093-6350

SCBT Portrait Logo
Seach Input

Histone cluster 1 H2AK 抑制因子

Histone cluster 1 H2AI Inhibitors represent a specialized category of chemical compounds designed to selectively obstruct the activity of histone cluster 1, with a specific focus on the H2AI subtype. Histones are essential proteins involved in packaging DNA into nucleosomes, forming the structural basis of chromatin. The designation H2AI identifies a variant of histone H2A, one of the core histones crucial for nucleosome assembly. The H2A family of histones plays a central role in the regulation of gene expression and the modulation of chromatin architecture. Inhibitors developed for Histone cluster 1 H2AI are meticulously crafted for specificity, aiming to selectively bind to key regions of this histone variant. This interaction potentially affects its binding to DNA and other proteins, thereby modulating chromatin dynamics.

The development of Histone cluster 1 H2AI Inhibitors necessitates an in-depth understanding of the structural characteristics of histone H2AI and its unique role within chromatin organization. These inhibitors are engineered with precision, aiming to selectively bind to crucial regions of Histone cluster 1 H2AI and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can investigate the consequences of inhibiting this particular histone variant, unraveling insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H2AI, significantly contributes to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.

関連項目

Items 1 to 10 of 11 total

展示:

产品名称CAS #产品编号数量价格应用排名

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
¥271.00
¥993.00
¥2347.00
24
(2)

恩替诺特是一种组蛋白去乙酰化酶抑制剂,可改变染色质结构,并可能影响组蛋白(包括 H2AK)的乙酰化状态。

GSK-J4

1373423-53-0sc-507551
100 mg
¥14385.00
(0)

GSK-J4 可抑制赖氨酸去甲基化酶,潜在地影响组蛋白去甲基化和基因的转录调控,包括 H2AK。

EPZ6438

1403254-99-8sc-507456
1 mg
¥745.00
(0)

EPZ-6438 靶向组蛋白甲基转移酶 EZH2,可能会影响组蛋白的甲基化和 H2AK 等基因的表达。

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
¥1726.00
¥6329.00
(1)

贝利诺司他是一种组蛋白去乙酰化酶抑制剂,可影响染色质结构,并可能影响组蛋白(包括 H2AK)的乙酰化状态。

UNC1999

1431612-23-5sc-475314
5 mg
¥1602.00
1
(0)

UNC1999 靶向组蛋白甲基转移酶的甲基转移活性,可能会影响 H2AK 的甲基化状态和表达。

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
¥1681.00
¥5303.00
¥6995.00
¥13527.00
¥23579.00
33
(3)

Trichostatin A 是一种强效组蛋白去乙酰化酶抑制剂,通过维持组蛋白(包括 H2AK)的乙酰化水平来影响基因表达。

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
¥1015.00
¥2685.00
¥3385.00
(0)

GSK343 可抑制 EZH2,潜在地影响组蛋白甲基化模式和基因的转录调控,包括组蛋白簇 1 H2AK。

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
¥5077.00
2
(0)

I-BET151 是一种 BET 溴链抑制剂,能破坏溴链蛋白与乙酰化组蛋白之间的相互作用,从而可能影响基因(包括 H2AK)的表达。

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
¥2933.00
¥10436.00
5
(1)

C646 是组蛋白乙酰转移酶的选择性抑制剂,可调节组蛋白的乙酰化并影响相关基因(包括 H2AK)的表达。

UNC0638

1255580-76-7sc-397012
10 mg
¥3554.00
(0)

UNC0638 可抑制组蛋白甲基转移酶 G9a,从而可能影响组蛋白的甲基化状态和基因(包括 H2AK)的表达。